BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
24.92
-0.33 (-1.31%)
May 29, 2026, 4:00 PM EDT - Market closed
BioLife Solutions Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 105.75 | 96.21 | 74.65 | 68.02 | 76.24 | 119.16 | |
Revenue Growth (YoY) | 26.08% | 28.89% | 9.75% | -10.79% | -36.02% | 147.79% |
Cost of Revenue | 19.25 | 34.1 | 24.55 | 26.7 | 29.33 | 82.11 |
Gross Profit | 86.5 | 62.12 | 50.1 | 41.32 | 46.91 | 37.05 |
Selling, General & Admin | 56.01 | 55.37 | 49.56 | 54.17 | 44.93 | 47.67 |
Depreciation & Amortization Expenses | -0.35 | 0.26 | 0.26 | 1.03 | 3.99 | 8.2 |
Research & Development | 8.01 | 7.57 | 4.75 | 5.52 | 8.67 | 11.82 |
Other Operating Expenses | 15.52 | 15.52 | - | -2.19 | -4.75 | 4.51 |
Total Operating Expenses | 79.19 | 78.72 | 54.57 | 58.52 | 52.83 | 72.21 |
Operating Income | 7.32 | -16.6 | -4.48 | -17.21 | -5.92 | -35.16 |
Interest Expense | -0.83 | -2.71 | 0.77 | 1.41 | 0.28 | 0.49 |
Other Non-Operating Income (Expense) | 4.13 | 1.82 | -3.58 | 6.39 | 1.36 | 6.62 |
Total Non-Operating Income (Expense) | 3.3 | -0.89 | -2.81 | 7.8 | 1.64 | 7.1 |
Pretax Income | 10.61 | -17.49 | -7.29 | -9.41 | -4.28 | -28.06 |
Provision for Income Taxes | 0.13 | 0.05 | -0.04 | -0.06 | 5.24 | 20.12 |
Net Income | -15.84 | -4.6 | -20.18 | -68 | -139.81 | -48.17 |
Earnings From Discontinued Operations | 7.54 | 7.54 | -11.4 | -55.85 | -140.19 | - |
Net Income to Common | -15.84 | -4.6 | -20.18 | -68 | -139.81 | -48.17 |
Shares Outstanding (Basic) | 48 | 48 | 46 | 44 | 42 | 39 |
Shares Outstanding (Diluted) | 49 | 49 | 46 | 44 | 43 | 39 |
Shares Change (YoY) | 3.29% | 5.60% | 5.37% | 1.50% | 11.87% | 41.01% |
EPS (Basic) | -0.07 | -0.09 | -0.44 | -0.42 | 0.01 | -0.23 |
EPS (Diluted) | -0.08 | -0.10 | -0.44 | -0.42 | 0.01 | -0.23 |
Shares Outstanding | 48.83 | 48.2 | 46.91 | 45.17 | 42.83 | 41.82 |
Free Cash Flow | 0.69 | 10.64 | 5.2 | -18.88 | -18.87 | -12.98 |
Free Cash Flow Growth | -93.51% | 104.40% | - | - | - | - |
Free Cash Flow Per Share | 0.01 | 0.22 | 0.11 | -0.43 | -0.44 | -0.34 |
Gross Margin | 81.80% | 64.56% | 67.11% | 60.75% | 61.53% | 31.09% |
Operating Margin | 6.92% | -17.26% | -6.00% | -25.30% | -7.77% | -29.51% |
Profit Margin | -9.93% | -12.61% | -11.77% | -17.87% | 0.51% | -40.43% |
FCF Margin | 0.65% | 11.06% | 6.97% | -27.76% | -24.75% | -10.89% |
EBITDA | 11.32 | -11.92 | 4.18 | -4.91 | 10.55 | -22.3 |
EBITDA Margin | 10.70% | -12.38% | 5.61% | -7.22% | 13.84% | -18.71% |
EBIT | 7.32 | -16.6 | -4.48 | -17.21 | -5.92 | -35.16 |
EBIT Margin | 6.92% | -17.26% | -6.00% | -25.30% | -7.77% | -29.51% |
Effective Tax Rate | 1.18% | -0.28% | 0.52% | 0.68% | -122.34% | -71.71% |